Merck & Co. Pushes Back On Modest Projections For Verquvo

 
• By Joseph Haas
broken paper red heart isolated on pink background, top view, flat lay
Vericiguat approval brings a novel mechanism of action to HFrEF patients

More from New Products

More from Scrip